Fruzsina Mezei | Nursing and Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Fruzsina Mezei
Università Cattolica del Sacro Cuore
Fruzsina Mezei
Affiliation Università Cattolica del Sacro Cuore
Country Italy
Scopus ID 57225091697
Documents 8
Citations 65
h-index 3
Google Scholar JlzScJMAAAAJ&hl
Subject Area Nursing and Health Professions
Event International Invention Awards
ORCID 0000-0001-5924-9781

Fruzsina Mezei is a researcher affiliated with Università Cattolica del Sacro Cuore whose scholarly activities contribute to nursing and health professions research through evidence-based investigation and interdisciplinary collaboration. Her published studies demonstrate engagement with healthcare improvement, scientific methodology, and clinical knowledge development. Indexed academic outputs and measurable citation indicators reflect the visibility of her work within international databases, supporting recognition for sustained contributions to healthcare research and innovation.[1]

Abstract

Fruzsina Mezei has established a developing academic profile within nursing and health professions through research emphasizing evidence-based practice, healthcare quality, and interdisciplinary collaboration. Her indexed publications contribute to scientific understanding by addressing clinically relevant questions and supporting informed healthcare decision-making. Bibliometric indicators demonstrate growing scholarly visibility, while citation performance reflects recognition by the wider research community. Through collaboration with healthcare researchers and institutions, her work promotes methodological rigor, knowledge dissemination, and practical application. These characteristics collectively illustrate an active research trajectory appropriate for academic recognition within international innovation and research award programs.[2]

Keywords

Nursing Research, Health Professions, Clinical Research, Evidence-Based Practice, Healthcare Innovation, Scientific Collaboration, Medical Education, Patient Care, Healthcare Quality, Research Impact.

Introduction

Academic research within nursing and health professions plays an essential role in advancing healthcare quality and improving patient outcomes through systematic investigation. Fruzsina Mezei contributes to this objective by participating in scholarly research that supports evidence generation, encourages interdisciplinary cooperation, and strengthens scientific understanding within healthcare environments while maintaining alignment with internationally recognized research standards.[3]

Research Profile

The research profile of Fruzsina Mezei reflects continued scholarly activity documented within Scopus and supported by measurable publication and citation metrics. Her affiliation with Università Cattolica del Sacro Cuore provides an environment encouraging multidisciplinary collaboration, academic excellence, and meaningful healthcare research addressing clinically relevant challenges across nursing and health professions.[1]

Research Contributions

Her scientific contributions emphasize rigorous investigation, collaborative publication, and dissemination of healthcare knowledge through peer-reviewed research. These studies contribute to understanding healthcare practice, clinical outcomes, and evidence-based approaches while supporting future investigations. Such contributions strengthen academic dialogue and encourage continuous improvements within nursing and related healthcare disciplines internationally.[4]

Publications

The documented publication record includes peer-reviewed journal articles indexed within Scopus, demonstrating consistent engagement with healthcare research. These publications collectively represent scientific productivity and collaboration while contributing evidence to professional literature. Their accessibility through international indexing services enhances discoverability, supports citation growth, and promotes broader academic communication across healthcare research communities.[1]

Research Impact

Research impact may be observed through publication visibility, citation performance, and scholarly engagement within international databases. The available bibliometric indicators demonstrate that Fruzsina Mezei’s work has attracted academic attention and contributes to ongoing scientific discussions. Such measurable outcomes indicate meaningful participation in healthcare research while supporting future collaborative opportunities and continued scientific development.[2]

Award Suitability

Considering documented scholarly productivity, international indexing, measurable citation indicators, and contributions to nursing and health professions, Fruzsina Mezei demonstrates characteristics commonly associated with candidates for research recognition. Her sustained academic engagement, commitment to evidence-based investigation, and collaborative scientific output align appropriately with the objectives of the International Invention Awards and similar research excellence programs.[5]

Conclusion

Fruzsina Mezei maintains a growing academic profile supported by indexed publications, scholarly citations, and interdisciplinary healthcare research. Her documented achievements illustrate meaningful scientific participation and demonstrate continued commitment to advancing nursing and health professions through evidence-based inquiry, making her research profile suitable for professional academic recognition and international visibility.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Fruzsina Mezei, Author ID 57225091697.
    https://www.scopus.com/pages/authors/57225091697
  2. ORCID. (n.d.). Fruzsina Mezei ORCID Record.
    https://orcid.org/0000-0001-5924-9781
  3. Journal article. (2022.). Digitális egészségügyi technológiák értékelése – Diabétesz applikációk Németországban.
    https://doi.org/10.53020/IME-2022-207
  4. Journal article. (2021.). Countrywide survey on utilization of medical devices by GPs in Hungary: advantages of the cluster-practice model.
    https://doi.org/10.1017/s1463423621000372
  5. International Invention Awards. (2026.). Official Award Website.
    https://inventionawards.org/

Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Tahir Turk | Health Professions | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Tahir Turk
Dow University of Health Sciences, Australia

Tahir Turk
Affiliation Dow University of Health Sciences
Country Australia
Scopus ID 37091848000
Documents 20
Citations 278
h-index 9
Subject Area Health Professions
Event International Invention Awards
ORCID 0000-0002-8119-4171

Tahir Turk is a researcher associated with Dow University of Health Sciences whose scholarly activities focus on public health, health promotion, nutrition-sensitive social protection, social and behaviour change communication (SBCC), and water, sanitation and hygiene initiatives. His publication record demonstrates engagement with evidence-based interventions designed to improve health outcomes in diverse communities and low- and middle-income country settings. Through interdisciplinary collaborations, his work contributes to the understanding of behavioural determinants of health and the development of context-specific communication strategies.[1]

Abstract

This article reviews the academic profile of Tahir Turk and highlights contributions to public health research, nutrition-sensitive interventions, behavioural communication strategies, and WASH-related initiatives. His publications demonstrate a commitment to co-design methodologies, systematic evidence synthesis, and community-centered health promotion. The body of work reflects practical applications of behavioural science within public health programs and supports the advancement of effective communication frameworks for improving population health outcomes.[2]

Keywords

Public Health, Health Promotion, Social and Behaviour Change Communication, Nutrition, WASH, Community Engagement, Co-design Research, Systematic Review.

Introduction

Modern public health challenges increasingly require integrated approaches that combine behavioural science, community participation, and evidence-informed interventions. Tahir Turk’s research addresses these priorities through studies examining nutrition-sensitive social protection programs, obesity prevention strategies, and sanitation-related behavioural change initiatives. His work contributes to contemporary discussions regarding the implementation and evaluation of public health communication programs.[3]

Research Profile

According to available scholarly metrics, Tahir Turk has authored twenty indexed publications, accumulating 278 citations and an h-index of 9. His primary subject classification falls within Health Professions, with interdisciplinary engagement across public health, nutrition, health communication, and implementation research. The research portfolio demonstrates sustained attention to improving health outcomes through participatory and culturally informed intervention models.[1]

Research Contributions

  • Development of co-designed WASH communication strategies in Kiribati.
  • Systematic review of social and behaviour change communication interventions within nutrition-sensitive social protection programs.
  • Integration of co-design methodologies into formative research frameworks for low- and middle-income countries.
  • Research supporting obesity prevention communication strategies in Pacific Island contexts.

Publications

  • Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati (2026).
  • Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes: A Systematic Review (2026).
  • Integrating co-design into formative research for a SBCC entry-point platform for nutrition-sensitive social protection programs (2025).
  • Conducting formative research during a pandemic threat to inform obesity prevention communication strategies in Tonga (2024).

Research Impact

The impact of Turk’s scholarship is reflected in its emphasis on practical implementation and community engagement. His studies support policymakers, public health practitioners, and development organizations seeking evidence-based approaches to behavioural change and nutrition improvement. The combination of systematic reviews, formative research, and co-design methods strengthens the applicability of findings across diverse health settings.[4]

Award Suitability

Tahir Turk’s contributions align with the objectives of the International Invention Awards by demonstrating innovation in health communication, participatory research design, and public health intervention development. The integration of behavioural science principles into real-world health programs illustrates scholarly originality and practical relevance. His research record provides evidence of sustained academic productivity and measurable scholarly influence within the field of health professions.[5]

Conclusion

The academic profile of Tahir Turk highlights a focused commitment to advancing public health through behavioural communication research, nutrition-sensitive programming, and participatory intervention design. His body of work contributes valuable insights for researchers and practitioners working to improve health outcomes through evidence-based and community-centered approaches.

References

  1. Elsevier. (n.d.). Scopus author details: Tahir Turk, Author ID 37091848000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37091848000
  2. Public Health in Practice. (2026). Co-designing water sanitation and hygiene (WASH) messages for a social and behaviour change campaign in Kiribati.
    DOI: https://doi.org/10.1016/j.puhip.2026.100821
  3. Nutrition Reviews. (2026). Effect of Integrating Social and Behavior Change Communication Strategies in Nutrition-Sensitive Social-Protection Programs on Specific Nutritional Outcomes.
    DOI: https://doi.org/10.1093/nutrit/nuaf063
  4. PLOS One. (2025). Integrating co-design into formative research for a SBCC entry-point platform.
    DOI: https://doi.org/10.1371/journal.pone.0310288
  5. Health Promotion Journal of Australia. (2024). Conducting formative research during a pandemic threat to inform the development of an obesity prevention strategy in Tonga.
    DOI: https://doi.org/10.1002/hpja.821
  6. medRxiv Preprint. (2024). Integrating co-design into formative research for nutrition-sensitive social protection programs.
    DOI: https://doi.org/10.1101/2024.09.08.24313037

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

John Dundon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. John Dundon | Medicine and Dentistry | Research Excellence Award 

Orthopedic Research Institute of New Jersey | United States

Dr. John M. Dundon is a board-certified orthopedic surgeon and clinician–scientist with a distinguished research profile focused on adult reconstruction, total hip and knee arthroplasty, surgical innovation, and value-based orthopedic care. As a Full Partner at Tri-County Orthopedics and previously at the Orthopedic Institute of New Jersey, Dr. Dundon combines high-volume clinical practice with impactful academic research aimed at improving surgical precision, patient outcomes, and healthcare efficiency in joint replacement surgery. A central theme of Dr. Dundon’s research is the optimization of total joint arthroplasty through advanced technologies, including computer-assisted navigation, imageless systems, and smart implants. His work has demonstrated that navigation-assisted techniques significantly improve component positioning accuracy in complex primary and revision total hip arthroplasty, directly contributing to reduced complications, improved biomechanics, and better long-term implant survival. He has also explored objective gait analysis using smart implants, showing how real-time data can guide early postoperative interventions and enhance functional recovery following total knee arthroplasty. Dr. Dundon has made notable contributions to perioperative care pathways and health systems research. His studies on multimodal pain management protocols have shown that opioid use, patient-controlled analgesia, and femoral nerve blocks can be safely reduced or eliminated without compromising patient comfort, aligning surgical practice with modern opioid-sparing strategies. Additionally, his work on bundled payment models and quality metrics has provided evidence that structured care initiatives can significantly improve outcomes while reducing readmissions and healthcare costs. The development of the Readmission Risk Assessment Tool (RRAT) further highlights his commitment to predictive analytics and patient optimization in arthroplasty. His research portfolio also addresses implant biomechanics, tribocorrosion, femoral stem sizing, leg-length discrepancy correction, and postoperative imaging utilization, reflecting a comprehensive approach to both technical and clinical challenges in orthopedic surgery. Dr. Dundon has authored influential review articles and textbook chapters, including contributions to Orthopedic Knowledge Update and The Adult Hip, which serve as key references for practicing surgeons and trainees worldwide. With an extensive record of peer-reviewed publications, national and international presentations, and leadership roles within major orthopedic societies such as the American Academy of Orthopaedic Surgeons and the American Association of Hip and Knee Surgeons, Dr. Dundon is widely recognized for bridging evidence-based research and clinical excellence. His research profile reflects sustained innovation, interdisciplinary collaboration, and a clear commitment to advancing the safety, effectiveness, and value of modern joint replacement surgery.

Citation Metrics (Scopus)

1000
600
400
200
50
0

Citations
641

i10index
20

h-index
9

Citations

i10-index

h-index

View Scopus Profile

Featured Publications

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.

Irineu Loturco | Health Professions | Best Researcher Award

Published on by Invention Awards

Prof Dr. Irineu Loturco | Health Professions | Best Researcher Award

Prof. Dr. Irineu Loturco | Federal University of Sao Paulo | Brazil 

Prof. Dr. Irineu Loturco Filho (born May 22, 1972, Brazil) is a distinguished researcher, educator, and practitioner in sports science, specializing in high-performance training, neuromuscular adaptations, strength, power, and speed development. He holds a degree in Sports from the University of São Paulo (1999), a Professional Master’s in High-Performance Sports from Universidad Autónoma de Madrid (2009), and both a Master’s (2010) and PhD (2014) in High-Performance Sports from Universidad Pablo de Olavide, Spain, where his research focused on the effects of training load sequencing on strength, speed, and muscle power. Loturco currently serves as Director of Sport Science & Research Leader at the Núcleo de Alto Rendimento Esportivo de São Paulo (NAR-SP), coordinating postgraduate programs in training methodology and supervising research on training periodization, performance monitoring, and neuromuscular development. He is also a professor and advisor at the Federal University of São Paulo (UNIFESP) and a visiting professor at the University of South Wales, contributing to both national and international sports science research. Over his career, he has worked with elite athletes and professional teams including Clube Atlético Mineiro, Sociedade Esportiva Palmeiras, and Sport Club Corinthians Paulista, as well as national organizations such as the Brazilian Football Confederation and Brazilian Karate Confederation. His current research investigates strategies to enhance athletic performance, including weighted vest training, seasonal performance variation, and injury prevention. Recognized internationally for his contributions, Loturco has received awards such as the 2019 SCS Investigator Award and honors for his work in adaptive sports and high-performance athlete development, solidifying his position as a leading authority in strength and conditioning science.

Profile: Orcid

Featured Publications

Survey Studies: Connecting Sport Science to Coaching Practice – International Journal of Sports Physiology and Performance

Training at Different Velocity Zones: Does It Really Matter? – International Journal of Sports Physiology and Performance

Neuromuscular and Performance Responses to Resisted Sprint Loads in Elite Female Sprinters

Effects of a Short-Term Ballistic Training Program on Performance and Strength Deficit in Elite Youth Female Soccer Players – Sports,

Effects of Loaded and Unloaded Jumps Used as Priming Activities in Elite Male Rugby Union Players

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Published on by Invention Awards

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

Carlos Escobar | Medicine and Dentistry | Best Researcher Award- 25576

Published on by Invention Awards

Prof. Dr. Carlos Escobar | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Carlos Escobar | Hospital La Paz, Madrid | Spain

Dr. Carlos Escobar Cervantes is a leading cardiologist and researcher based in Madrid, Spain. With over two decades of experience in cardiovascular medicine, he has held esteemed roles in top Spanish hospitals, contributed prolifically to scientific literature, and has played leadership roles within major cardiology societies. He currently serves as Facultativo Adjunto del Servicio de Cardiología at Hospital Universitario La Paz and is the Scientific Director of the Consorcio DTX, focusing on digital therapeutics (DTx) and AI in health. His work bridges clinical expertise and digital innovation, making him a pioneer in the integration of artificial intelligence in cardiovascular care. Dr. Escobar’s dedication extends beyond patient care—he is also a respected academic and educator, shaping future medical professionals. His contribution to cardiovascular pharmacology, hypertension, ischemic heart disease, and public health through clinical trials, publications, and professional society work makes him an exemplary candidate for international recognition.

Profile

Scopus

Education

Dr. Carlos Escobar Cervantes earned his Medical Degree in Medicine and Surgery from the Universidad Autónoma de Madrid (1993–1999). He pursued academic excellence and scientific inquiry further by completing a PhD in Medicine at the Universidad de Alcalá in 2007, where he was awarded the prestigious distinction of Sobresaliente Cum Laude, by unanimous decision of the examining board. This rigorous academic path provided him with a strong foundation for his career in internal medicine, clinical cardiology, and scientific research. Additionally, his commitment to academic growth is reflected in his successful qualification as a Profesor Ayudante Doctor recognized by ANECA in June 2011. Further enriching his academic and leadership portfolio, Dr. Escobar completed the Leadership Development Program in Public Healthcare Organizations from ESADE Business School (2011–2012), one of Spain’s most prestigious business institutions. His education uniquely combines clinical, scientific, and managerial expertise—vital for innovative cardiovascular leadership.

Professional Experience

Dr. Escobar Cervantes has held successive and prestigious roles in cardiology across some of Madrid’s foremost healthcare institutions. He began his career as a Médico Adjunto de Cardiología at Hospital Universitario Ramón y Cajal (2006–2008), then transitioned to Hospital Universitario Infanta Sofía (2008–2012), and has been serving at Hospital Universitario La Paz since 2012. Currently, he also coordinates outpatient cardiology services and care continuity at La Paz, a role he took on in June 2023, showcasing his capacity for healthcare system organization and innovation. Since December 2023, Dr. Escobar has been the Scientific Director of the Consorcio DTX, focused on the application of digital health tools, including AI, in cardiology. He is also the Co-founder of Samira DTX, emphasizing his proactive stance in developing evidence-based digital therapeutic solutions. His career represents a seamless integration of bedside excellence, scientific leadership, and organizational impact in Spanish and international cardiology.

Research Interests

Dr. Escobar’s research focuses on ischemic heart disease, arterial hypertension, atrial fibrillation, and pulmonary thromboembolism. As both principal investigator and co-investigator, he has played key roles in clinical trials exploring innovative therapies in these domains. In recent years, he has expanded his research to encompass digital therapeutics (DTx) and the application of artificial intelligence (AI) in cardiovascular medicine. He is an active contributor to the Sociedad Española de Cardiología (SEC) and the European Society of Cardiology, where he is a member of the cardiovascular pharmacology and hypertension working groups. His research is deeply translational—bringing bench-side developments to bedside application. His commitment to improving cardiovascular care outcomes through technological innovation, patient-centered care models, and robust clinical investigation underscores his status as a forward-thinking leader in cardiovascular science. Dr. Escobar’s dual commitment to both scientific discovery and clinical impact has made him a valued voice in the cardiology research community.

Awards and Professional Recognition

Dr. Carlos Escobar is a highly respected figure in cardiology, having served as President of the Clinical Cardiology Section of the Sociedad Española de Cardiología (SEC). He has been a member of the SEC’s Research Agency and is an active contributor to several working groups under both SEC and the European Society of Cardiology (ESC). His academic and research contributions have earned him memberships in international editorial boards such as the World Journal of Hypertension, ISRN Nephrology, and the Journal of Cardiology and Therapeutics. His peer-review activity includes esteemed journals like Annals of Internal Medicine, Diabetes Care, and the Journal of Hypertension, reflecting his reputation as an authority in cardiovascular science. These honors reflect a career distinguished not only by scientific productivity but also by community trust and professional excellence. His leadership, publications, and collaborative spirit make him a worthy nominee for high-level international awards.

Publications

Cost-utility analysis of dapagliflozin for the treatment of symptomatic chronic heart failure in Spain

The gut microbiota and its role in the development of cardiovascular disease

Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis

Artificial intelligence: a promising tool for the clinical cardiologist

Magnitude of chronic kidney disease in Spain

Conclusion

Dr. Carlos Escobar Cervantes exemplifies the union of clinical excellence, academic integrity, and technological foresight. His contributions to cardiology span groundbreaking clinical research, digital health innovation, and transformative educational leadership. His work has directly improved cardiovascular care standards in Spain and beyond, earning him recognition across editorial boards, societies, and digital medicine consortia. Dr. Escobar is not only a scientific leader but also an innovator, teacher, and strategist, positioning him as a well-rounded and future-focused candidate for any top-tier international medical or scientific award. His pioneering initiatives in AI-driven cardiovascular therapeutics, combined with his extensive academic publications and clinical leadership, embody the spirit of 21st-century medical excellence. He is therefore highly recommended for recognition in awards celebrating innovation, excellence, and translational impact in cardiovascular medicine.

Mr. Fayez Alanazi | Mental Health | Best Researcher Award

Published on by Invention Awards

Mr. Fayez Alanazi | Mental Health | Best Researcher Award

Saudi Red Crescent Authority, Saudi Arabia.

Fayez Mutairan Alanazi is an experienced emergency medical professional at the Saudi Red Crescent Authority, with over a decade in frontline medical response. He holds a Master’s degree in Risk Management and has expertise in trauma life support and major incident management. His research focuses on mental health in emergency medical services, particularly PTSD among paramedics. He has contributed to discussions on occupational stress and resilience-building programs, shaping mental health interventions for frontline responders.

Profile

Google Scholar

🎓 Education

Fayez Mutairan Alanazi has a strong academic foundation in emergency medical services and risk management. He earned a Master’s degree in Risk Management from Midocean University (2024), equipping him with expertise in crisis response and disaster preparedness. In 2020, he completed a Higher Diploma in Health Media at Imam Mohammad bin Saud University, enhancing his communication skills in healthcare settings. His Bachelor’s degree in Emergency Medical Services from Inaya College (2017) provided him with in-depth knowledge of prehospital care. Additionally, he holds a Diploma in Emergency Medicine from Future Gate Institute (2012), which laid the foundation for his career in frontline emergency response.

💼 Experience

Fayez Mutairan Alanazi has been a dedicated Emergency Medical Services Professional at the Saudi Red Crescent Authority since 2012, with over a decade of hands-on experience in frontline medical response. His role involves providing critical prehospital care, managing major incidents, and ensuring efficient trauma life support. In addition to his medical career, he also worked as a Gym Manager for five years, where he specialized in fitness and rehabilitation programs, promoting physical well-being and injury recovery. His combined experience in emergency response and health management has strengthened his expertise in both medical intervention and preventative healthcare.

🔬 Research Interests

Mental Health & Psychology: PTSD among paramedics, resilience-building programs

Prehospital Care: Innovation and AI applications in emergency medical diagnosis

Trauma & Emergency Response: Major incident management and medical response strategies

📚 Publications

Alanazi, F. M., et al. (2025). Assessing post-traumatic stress disorder among paramedics on the frontlines at the Saudi Red Crescent. European Journal of Trauma & Dissociation, 9(1), 100492. [DOI Link] (Cited by X articles)

Saudi Paramedics' Perceptions of Innovation in Prehospital Care for Trauma Patients – This study explores how paramedics in Saudi Arabia perceive and adopt new technologies and practices in trauma management, aiming to improve emergency response efficiency.(on going)

Artificial Intelligence Applications in Myocardial Infarction Diagnosis and Management: A Systematic Review with a Focus on Adoption in Saudi Arabia – This research investigates the role of AI in diagnosing and managing heart attacks, emphasizing its potential integration into Saudi Arabia’s healthcare system to improve early detection and patient outcomes.(on going)